← Back to Search

Sleep Management for Muscle Weakness

N/A
Recruiting
Led By Lance Bollinger, PhD
Research Sponsored by Lance Bollinger
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18 and 50 years
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and study completion, approximately 14 days
Awards & highlights

Study Summary

This trial will test how sleep and no bearing weight on leg affects muscle strength & posture. Participants will sleep & walk on one leg & do tests & imaging. Researchers will compare adequate sleep & restricted sleep to see effects.

Who is the study for?
This trial is for adults aged 18-50 who exercise regularly, including both aerobic (>150min/week) and resistance exercises (>1 time/week), and sleep at least 7 hours nightly. It's not for those with recent injuries, certain medical conditions like heart arrhythmias or muscle disorders, pregnant women, or individuals on sleep medications.Check my eligibility
What is being tested?
Researchers are testing how lack of sleep combined with non-weight bearing on one leg affects muscle strength and balance. Participants will have different sleep schedules while using only one leg to walk. They'll undergo tests for posture control, muscle strength, and get their muscles imaged.See study design
What are the potential side effects?
While the study itself may not directly cause side effects beyond normal discomfort from exercise or fatigue due to sleep restriction, potential indirect side effects could include increased tiredness, mood changes, decreased alertness and performance impairment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 50 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and study completion, approximately 14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and study completion, approximately 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Interpolated Twitch
Change in Single Leg Land and Hold
Change in Single Leg Stand (SLS)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep Restriction (SR)Experimental Treatment1 Intervention
The research team will provide participants with a pair of shoes to wear throughout the study. The right shoe will be modified to include a 5cm (approximately 2") rocker-style platform which will keep the left leg suspended during walking. Participants will also be provided with a pair of short crutches to assist with walking. Participants in the SR group will sleep only 5 hours for three consecutive nights.
Group II: Sleep Adequate (SA)Active Control1 Intervention
The research team will provide participants with a pair of shoes to wear throughout the study. The right shoe will be modified to include a 5cm (approximately 2") rocker-style platform which will keep the left leg suspended during walking. Participants will also be provided with a pair of short crutches to assist with walking. Participants in the SA group will sleep for 9 hours for three consecutive nights.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep Restriction
2016
N/A
~470

Find a Location

Who is running the clinical trial?

Lance BollingerLead Sponsor
National Aeronautics and Space Administration (NASA)FED
24 Previous Clinical Trials
1,746 Total Patients Enrolled
Lance Bollinger, PhDPrincipal InvestigatorUniversity of Kentucky

Media Library

Sleep Restriction (SR) Clinical Trial Eligibility Overview. Trial Name: NCT05956964 — N/A
Muscle Weakness Research Study Groups: Sleep Restriction (SR), Sleep Adequate (SA)
Muscle Weakness Clinical Trial 2023: Sleep Restriction (SR) Highlights & Side Effects. Trial Name: NCT05956964 — N/A
Sleep Restriction (SR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05956964 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research trial permit individuals aged 50 and over to participate?

"The requirements for applicants of this trial are between 18 and 50 years old. There are 87 studies specifically designed to serve those under the age of eighteen, while 201 cater towards seniors aged 65 or higher."

Answered by AI

Is it possible for me to register as a participant in this medical study?

"Potentially eligible patients for this medical trial should display signs of muscular diminishment and fall between the ages 18 to 50. So far, 20 participants have been accepted."

Answered by AI

How many participants are currently undergoing the clinical trial?

"Affirmative. Clinicaltrials.gov has the latest information that this trial, initially posted on August 5th 2023, is actively recruiting for participants. The search parameters are set to find approximately 20 patients at a single site."

Answered by AI

Are there still openings for volunteers in this trial?

"This clinical trial is presently in the recruitment phase, with its initial post being on August 5th 2023 and its most recent update occurring on July 21st of the same year."

Answered by AI
~10 spots leftby Dec 2024